Condition: Low Back Pain · Sponsor: R3 Stem Cell
This is a Pilot Study that is an open label, prospective, non-controlled study in which the safety and feasibility of Wharton's Jelly (WJ) allograft will be evaluated in 100 participants suffering with low back pain.
This description comes directly from the study's public registry record.
David L Greene, MD, PhD, MBA · (602) 677-8981 · dgreene@r3medicalresearch.com
Katherine Minter-Dykhouse, PhD · 4803066256 · kmd@bello.bio
Always discuss trial participation with your own doctor first.
| R3 Anti Aging Scottsdale | Scottsdale, Arizona, United States | Recruiting |
| R3 Anti Aging Beverly Hills | Beverly Hills, California, United States | Recruiting |
| Scheer Medical Wellness | New York, New York, United States | Recruiting |
| Dr. Duc (Steve) Le, MD | Cleveland, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06361485